Track Categories
The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.
Oncology is the branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Oncologists are doctors who specialize in the treatment of cancer and work closely with other healthcare professionals, such as radiologists, pathologists, and surgeons, to develop a comprehensive treatment plan for cancer patients.
There are several types of cancer treatments, including surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, hormone therapy, and stem cell transplant. The choice of treatment depends on various factors, such as the type and stage of cancer, the patient's overall health, and their personal preferences.
Clinical Oncology is a subspecialty of oncology that involves the diagnosis and treatment of cancer in patients. Clinical oncologists are medical professionals who specialize in the management of cancer patients, including the use of various treatment modalities such as chemotherapy, radiation therapy, immunotherapy, targeted therapy, and other forms of systemic therapy.
Clinical oncologists work closely with other healthcare professionals, including surgeons, radiologists, pathologists, and nurses, to provide comprehensive and coordinated care for cancer patients. They evaluate patients, determine the stage and extent of cancer, and develop a personalized treatment plan that is tailored to the individual patient's needs.
Oncology Nursing is a specialized field of nursing that focuses on caring for patients with cancer. Oncology nurses work in a variety of settings, including hospitals, clinics, and outpatient centers. They play a crucial role in the patient's cancer journey, providing emotional support, symptom management, and education about their disease and treatment options. Overall, oncology nursing is a demanding but rewarding profession that calls for a strong dedication to patient care and a desire to enhance the lives of cancer patients.
Organ-defined cancers are a group of cancers that are named based on the organ or tissue where they originate. Examples of organ-defined cancers include lung cancer, breast cancer, colon cancer, prostate cancer, and skin cancer, among others.
Each type of organ-defined cancer has unique characteristics, including different risk factors, symptoms, and treatment options. For instance, while breast cancer is more prevalent in women and may be influenced by factors including age, family history, and lifestyle, lung cancer is closely linked to tobacco use.
Ongoing research in the field of organ-defined cancers is focused on improving the accuracy of diagnosis and staging, developing new and more effective treatments, and identifying ways to prevent and reduce the risk of these cancers. The ultimate goal is to enhance patient outcomes and quality of life for people suffering from organ-defined malignancies
Innovations in cancer research have brought about significant improvements in the understanding and treatment of cancer. Advancements in precision medicine and immunotherapy have allowed for targeted therapies that specifically address the unique genetic characteristics of an individual's cancer, leading to improved treatment outcomes. Liquid biopsy and CAR-T therapy have also shown promising results in detecting cancer cells and modifying the immune system to fight cancer, respectively. Furthermore, the development of CRISPR gene editing technology has opened up new possibilities for targeted cancer treatments, potentially revolutionizing cancer therapy. The continued progress in cancer research offers hope for better treatment options and improved patient outcomes, as well as the possibility of finding a cure for cancer in the future.
Biomarkers of cancer stem cells can be used to identify and isolate these cells from other cells in the tumor. These biomarkers may include the expression of certain cell surface markers or genetic mutations that are unique to cancer stem cells. By studying these biomarkers, researchers can gain a better understanding of the biology of cancer stem cells and develop targeted therapies to eliminate them.
Furthermore, biomarkers of cancer stem cells can also be used to monitor treatment response and disease progression. They can provide information about the presence and activity of cancer stem cells before and after treatment, helping to guide treatment decisions and assess the effectiveness of therapy.
Overall, biomarkers of cancer stem cells offer a promising avenue for improving cancer diagnosis, treatment, and monitoring. They hold the potential to advance our understanding of cancer stem cells and ultimately lead to better outcomes for patients with cancer.
Cancer nanotechnology is an emerging field that involves the use of nanoparticles to improve the detection, diagnosis, and treatment of cancer. Nanoparticles are tiny particles that range in size from 1-100 nanometers and can be designed to interact specifically with cancer cells or tissues.
In cancer detection, nanoparticles can be used to improve imaging techniques such as MRI or PET scans, allowing for more accurate and earlier detection of tumors. In cancer treatment, nanoparticles can be used to deliver drugs directly to cancer cells, improving the efficacy of chemotherapy and reducing side effects. Furthermore, nanoparticles can be used to enhance the immune response to cancer by delivering immunotherapies directly to cancer cells or by serving as adjuvants that boost the immune system's ability to recognize and attack cancer cells.
Overall, cancer nanotechnology offers a promising approach to improving cancer detection, diagnosis, and treatment. It has the potential to transform cancer therapy, improving patient outcomes and quality of life.
Cancer clinical trials are research studies that test new treatments or interventions for cancer. These trials are essential for developing new cancer treatments and improving patient outcomes. Clinical trials can test a variety of interventions, including new drugs, radiation therapy, surgery, and other therapies. They may also involve combinations of existing treatments or modifications to existing treatments. Overall, cancer clinical trials are critical for advancing the field of oncology and developing new treatments for cancer. They offer hope for improved patient outcomes and a better quality of life and provide an opportunity for patients to contribute to the fight against cancer.
Neuro-oncology is a field of medicine that focuses on the diagnosis and treatment of cancers that affect the brain and nervous system. These cancers, known as primary brain tumors or central nervous system tumors, can originate in the brain or spinal cord, or they may result from cancer cells that have spread from other parts of the body. The management of neuro-oncological tumors often requires a multidisciplinary approach, involving neurosurgeons, radiation oncologists, medical oncologists, neurologists, and other specialists. The treatment plan may include surgery, radiation therapy, chemotherapy, or a combination of these treatments.
Blood Cancer influences the creation and capability of your platelets. The majority of these diseases start in your bone marrow, where blood is delivered. Immature micro influences: organisms in your bone marrow mature and form into three sorts of platelets: red platelets, white platelets, or platelets. In most blood diseases, the typical platelet improvement process is interfered with by the uncontrolled development of a strange kind of platelet. These unusual platelets, or harmful cells, keep your blood from performing a large number of its capabilities, such as fending off contamination or forestalling serious death.
Breast tumors can begin from various pieces of the bosom. The bosom is an organ that sits on top of the upper ribs and chest muscles. There is a left and right breast, and everyone has chiefly organs, conduits, and greasy tissue. Ladies, the bosom makes and conveys milk to take care of babies and newborn children. How much greasy tissue is in the bosom determines the size of each breast. Its therapy depends on the phase of the disease. It might comprise chemotherapy, radiation, chemical treatment, and medical procedures.
Oropharyngeal cancer is a malignant growth in the oropharynx, which is the center piece of your throat (pharynx). Side effects include a sensitive throat that doesn't disappear; a bump in the throat, mouth, or neck; hacking up blood; a white fix in the mouth; and different side effects. Therapies might incorporate a medical procedure, radiation treatment, chemotherapy, designated drug treatment, and immunotherapy. Oropharyngeal cancer is a sort of head and neck malignant growth where malignant growth cells are found inside a region of your throat called your oropharynx. Over 90% of oropharyngeal malignant growths are squamous cell carcinomas, which are diseases emerging from the surface cells coating your mouth and throat.
Colon cancer, also known as colorectal cancer, is a type of cancer that affects the colon and rectum. It occurs when abnormal cells grow uncontrollably in the lining of the colon or rectum and can spread to other parts of the body if left untreated. Risk factors for colon cancer include a family history of the disease, a personal history of colon polyps or inflammatory bowel disease, a diet high in red meat or processed foods, and a sedentary lifestyle. Symptoms may include changes in bowel habits, blood in the stool, abdominal pain, and weight loss.
Pelvic cancer is any malignant growth that beginnings in a women's reproductive organs. Five primary kinds of disease influence a lady's conceptive organs are cervical, ovarian, uterine, vaginal and vulvar. Collectively, they are alluded to as gynecologic disease. A 6th sort of gynecologic malignant growth is the exceptionally intriguing fallopian tube disease. The five gynecologic tumors start in better places inside a lady's pelvis, which is the region beneath the stomach in the middle of between the hip bones. Each gynecologic disease is extraordinary, with various signs and side effects, different gamble factors and different anticipation methodologies. All ladies are in danger for gynecologic malignant growths, and chance increments with age. At the point when gynecologic malignant growths are viewed as ahead of schedule, therapy is best.
Skin Cancer is the wild development of strange cells in the epidermis, the furthest skin layer, brought about by unrepaired DNA harm that triggers changes. These changes lead the skin cells to increase quickly and structure harmful cancers. The fundamental kinds of skin malignant growth are basal cell carcinoma (BCC), squamous cell carcinoma (SCC), melanoma and Merkel cell carcinoma (MCC). Fortunately, on the off chance that skin cancer is gotten early, your dermatologist can treat it with next to zero scarring and high chances of disposing of it completely. Frequently, the specialist might try and identify the development at a precancerous stage, before it has turned into an out and out skin disease or infiltrated underneath the outer layer of the skin.
The method involved with actuating, supplanting, designing, or recovering human cells, tissues, or organs to reestablish or layout typical capabilities alludes to regenerative medication. The regenerative medication field includes tissue design, cell treatment, quality treatment, participation in malignant growth therapy, and the advancement of disease models to work on the comprehension of malignant growth science.
Herbal medication uses plants or plant extracts to cure illness and promote wellness. There is not enough logical evidence to consider it as a treatment for a medical condition. Herbal medicines may have negative side effects and interact with other drugs. When made outside of the UK, home-grown prescriptions may not be directed, and their contents may vary. It is safest to obtain homemade remedies from a fully licensed herbal practitioner if you decide to do so.
Cancer immunology is a field of medicine that studies how the immune system responds to cancer cells and how this response can be harnessed to develop new cancer treatments. The immune system plays a critical role in identifying and eliminating abnormal cells, including cancer cells. However, cancer cells can evade detection by the immune system by adopting various strategies, such as suppressing the immune response or producing molecules that inhibit immune cell activity. Immunotherapy is a type of cancer treatment that aims to enhance the immune response against cancer cells. Cancer immunology represents a promising area of cancer research that has already shown significant progress in the development of new cancer treatments. As our understanding of the immune response to cancer continues to expand, we can expect to see further advancements in this field in the years to come.
Cancer treatment has come a long way in recent years, thanks to numerous advancements in research and technology. Immunotherapy has emerged as a promising new approach to cancer treatment, leveraging the patient's own immune system to fight cancer cells. Precision medicine and targeted therapy allow doctors to tailor treatment to each patient's unique genetic profile. CAR-T therapy has shown great potential for treating certain types of leukemia and lymphoma, and advances in radiation therapy and minimally invasive surgery have made these treatments more effective and less invasive. Personalized cancer vaccines are also being developed, which teach the immune system to recognize and attack cancer cells based on the patient's unique genetic profile. Overall, these advancements have greatly improved the prognosis for many cancer patients and offer hope for continued progress in the fight against cancer.
Chemotherapy is a drug that employs strong chemicals to kill cells that grow quickly in your body. Chemotherapy is the preferred method to treat cancer because cancer cells grow and spread significantly faster than all of the body's cells. There are numerous chemotherapy medicines available. To treat a wide range of tumors, drugs used for chemotherapy can be administered alone or in combination. Though chemotherapy is an effective treatment for many types of cancer, it also has a risk of adverse effects. Some chemotherapy side effects are easy to deal with, while others can be life-threatening.
Tumor and cancer are related terms, but they are not interchangeable. A tumor is an abnormal growth of cells that may be benign (not cancerous) or malignant (cancerous). Benign tumors do not spread to other parts of the body and are usually not life-threatening. However, they can still cause problems by pressing on nearby tissues or organs. Cancer, on the other hand, is a disease characterized by the uncontrolled growth and spread of abnormal cells. Cancer cells can invade nearby tissues and organs, and they can also spread to other parts of the body through the bloodstream or lymphatic system. If left untreated, cancer can be life-threatening.
In other words, cancer is a type of disease that is characterized by the presence of malignant tumors. Not all tumors are cancerous, but all cancers involve the growth of abnormal cells that can spread to other parts of the body. It is important to note that early detection and treatment of both tumors and cancers can significantly improve the chances of successful treatment and recovery. Regular medical check-ups and screenings can help detect tumors and cancers at an early stage, when they are more treatable.